News Category
Regentis Biomaterials reports progress in its Phase III GelrinC trial for knee cartilage repair and receives European approval for a manufacturing pro...
As more Americans lose health insurance due to rising premiums and recent legislative changes, the financial and health impacts are expected to be fel...
Nanox Imaging Ltd. has signed a distribution agreement with SOLME RC to bring its Nanox.ARC 3D tomosynthesis system to Costa Rica, marking its third L...
Quantum BioPharma's Lucid-MS, a first-in-class drug that protects and rebuilds myelin, has received FDA clearance for a Phase 2 trial that could trans...
TransCode Therapeutics names John Tattory as interim CFO following Tom Fitzgerald's retirement, bringing extensive financial leadership to guide the c...
VERAXA Biotech's appointment of Dr. Christoph Erkel as chief scientific officer strengthens its leadership as it advances its BiTAC® T-cell engager an...
Earth Science Tech Inc. reported strong revenue growth and improved financial health for FY2026, demonstrating the success of its vertically integrate...
SS Innovations International (NASDAQ: SSII) has launched Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo using its SSi Man...
Quantum BioPharma's FDA clearance for a phase 2 trial of Lucid-MS, a first-in-class myelin-repair therapy, could transform the multibillion-dollar mul...
Quantum BioPharma's Lucid-MS, a first-in-class PAD2 inhibitor, has received FDA clearance to begin a Phase 2 trial for multiple sclerosis, potentially...
Quantum BioPharma's FDA clearance for a phase 2 trial of Lucid-MS represents a historic first in multiple sclerosis treatment, potentially unlocking a...
SS Innovations International reported a 79% increase in procedures using its SSi Mantra surgical robotic system, highlighting its rapid global adoptio...
Helus Pharma's CEO will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference, highlighting the company's advanced clinica...
Onco-Innovations' CMO detailed the company's novel PNKP-targeting drug candidate ONC010, which uses synthetic lethality and nanoparticle delivery to p...
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, has received FDA clearance to begin a Phase 2 trial in multiple sclerosis,...
Visory Health's recognition underscores its commitment to fostering innovation through a flat, inclusive culture that directly improves prescription a...
The American Stroke Association's new guideline emphasizes that stroke recovery is an ongoing, personalized process, highlighting the importance of ea...
Earth Science Tech's strategic focus on vertical integration and dual-segment targeting has built a self-sustaining business model, positioning the co...
Kairos Pharma's CEO presentation at a major investment conference underscores the company's progress in developing ENV-105, an antibody aimed at rever...
An expert highlights the overlooked shortcomings in UTI diagnosis, emphasizing the need for advanced tools to address recurrent infections and their i...
Nutriband's CEO participation at the Nasdaq LaB summit underscores the importance of its AVERSA technology in addressing opioid abuse, potentially inf...
Silo Pharma's participation in the IPAC-RS 2026 Nasal Innovation Forum underscores its commitment to advancing SPC-15, a nose-to-brain therapy for PTS...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a significant milestone for a novel myelin-repair approach to multiple...
Quantum BioPharma's multiple sclerosis drug candidate Lucid-MS has received FDA clearance to begin a Phase 2 trial, a rare milestone for a micro-cap b...
Helus Pharma's CEO participation in a major investment conference highlights the company's progress in developing novel serotonergic agonists for ment...
The 2026 Disruptive Growth & Life Sciences Conference, organized by Moody Capital Solutions, is set to provide a structured platform for under-covered...
GeoVax applauds the new global mpox vaccine stockpile and highlights its GEO-MVA candidate's readiness to support a diversified supply.
The August Wellness Index Report highlights the critical role of translational longevity in bringing scientific breakthroughs to patients, featuring e...
Greenland Mines is spinning off its biotech division in Q4 2026 to focus on rare earths, following the completion of its Sarfartoq acquisition and a p...
Nano-X Imaging's new distribution agreement with Associated X-Ray Imaging Corp. aims to increase access to its FDA-cleared Nanox.ARC 3D tomosynthesis ...
SS Innovations International is leveraging its established Indian base to expand its SSi Mantra surgical robotic system globally, with strong quarterl...
Scinai Immunotherapeutics has strategically exited its PC111 license with PinCell to concentrate resources on its NanoAb platform and CDMO business, a...
Onco-Innovations Ltd. strengthens its clinical foundation for ONC010, a nanoparticle-encapsulated PNKP inhibitor, through manufacturing milestones, IN...
Roth Capital Partners announces a series of investor conferences and sponsorships from September 2026 to June 2027, highlighting its focus on growth s...
OS Animal Health's presentation at the Moody Capital conference underscores its strategic push to secure USDA conditional approval for OST-HER2, a pro...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS, a first-in-class myelin repair candidate, marks a pivotal step toward treating the ...
A new study from Washington University School of Medicine highlights the growing role of laser interstitial thermal therapy (LITT) in treating brain c...
Ocumetics Technology Corp. has initiated patient recruitment for the Group Two human clinical study of its next-generation accommodating intraocular l...
Quantum BioPharma's FDA clearance for a phase 2 trial of Lucid-MS marks a potential breakthrough in treating multiple sclerosis by targeting myelin re...
NanoViricides' registration of its Phase II Ebola trial in the DRC marks a critical step in evaluating NV-387 as a potential treatment for Ebola, with...
Nutriband receives USPTO Notice of Publication for trademarks related to its abuse-deterrent fentanyl patch, moving closer to commercialization of a p...
The FDA has cleared Quantum BioPharma's IND application to begin a Phase 2 trial of Lucid-MS in multiple sclerosis, a key milestone for the first-in-c...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS, a novel remyelination agent, marks a significant step in MS treatment and draws ana...
Quantum BioPharma's FDA clearance to initiate a Phase 2 trial of Lucid-MS marks a pivotal step toward a novel therapy for multiple sclerosis that targ...
Tonix Pharmaceuticals elevates Thomas Englese to Chief Commercial Officer to lead commercialization efforts for its fibromyalgia treatment TONMYA and ...
Synbio International's exclusive licensing deal with MD PHD Wellness provides immediate access to proprietary nutraceutical products, accelerating its...
AcroMeta Group Limited announced a strategic partnership with Macro HRD SG Pte. Ltd. to enter the ambient temperature cellular logistics market, inclu...
As flu season nears, health experts emphasize the importance of annual flu shots and preventive measures to protect individuals and communities.
